Search

Dr. Perales was formally sworn in during the 2023 Tandem Transplantation and Cellular Therapy Meetings of ASTCT and the Center for International Blood and Marrow Transplant Research (CIBMTR) on February 18.

… Monday, February 20, 2023 Miguel-Angel Perales, MD , of Memorial Sloan Kettering Cancer Center (MSK), has been named President of The American Society for Transplantation and Cellular Therapy (ASTCT) for 2023-2024. Dr. Perales was formally sworn in during the 2023 Tandem Transplantation and Cellular

Research recently published by MSK scientists suggests that the best way to fight dangerous bacteria may be with other bacteria.

… Tuesday, June 20, 2017 Summary People with cancer are particularly susceptible to infections because treatment often damages their immune system. Now research is suggesting that the best way to combat these dangerous infections may be with other, nonharmful bacteria. Highlights Antibiotics are an important

A new study by a team of 12 thoracic surgeons at Memorial Sloan Kettering Cancer Center (MSK), published recently in the Annals of Surgery,([i]) is the first to identify a comprehensive list of clinical factors significantly associated with referring patients with stage 1 NSCLC to SBRT.

… Tuesday, November 5, 2024 Minimally invasive surgery (MIS) and stereotactic body radiotherapy (SBRT) are both used to treat stage 1 non-small cell lung cancer (NSCLC). While MIS remains the standard of care for patients with operable disease, selecting which patients should be referred for SBRT has been

A newly identified group of immunosuppressive cells could provide insight into the effects of immunotherapy drugs.

… Tuesday, June 12, 2018 Summary MSK researchers have identified a new group of immunosuppressive cells that are affected in opposite ways by two common checkpoint inhibitors often given in combination. These cells are easily detectable in the blood and could help doctors make immunotherapy work better

A commentary by members of Memorial Sloan Kettering Cancer Center’s (MSK) Bobst International Center along with members of the Bloomberg New Economy International Cancer Coalition (the “Coalition”) calls for global collaboration to reimagine patient-centric cancer clinical trials. The piece was published in the April 19, 2022, “The Future of Cancer Research” special Focus edition of the journal Nature Medicine.

… Thursday, April 21, 2022 A commentary by members of Memorial Sloan Kettering Cancer Center’s (MSK) Bobst International Center along with members of the Bloomberg New Economy International Cancer Coalition (the “Coalition”) calls for global collaboration to reimagine patient-centric cancer clinical trials

Scott Callahan is the second Gerstner Sloan Kettering student to receive the Joanna M. Nicolay Melanoma Foundation grant, which supports exceptional melanoma research by graduate students.

… Monday, April 28, 2014 Scott Callahan, a second-year student studying in the laboratories of Lorenz Studer in the Developmental Biology Program and Richard M. White in the Cancer Biology and Genetics Program , was awarded a $10,000 melanoma research grant by the Joanna M. Nicolay Melanoma Foundation

Memorial Sloan Kettering Cancer Center (MSK) today celebrated the opening of a $1.5 billion state-of-the-art cancer treatment facility with government officials, members of the Boards of Overseers and Managers, and staff. Opening for patient care next month, the 750,000-square-foot building is the institution’s — and the city’s — largest freestanding cancer care facility. The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center is a healing community dedicated to patient-centered care, made possible by a landmark donation and a pioneering vision that signifies a new era of cancer care.

… Tuesday, December 10, 2019 Memorial Sloan Kettering Cancer Center (MSK) today celebrated the opening of a $1.5 billion state-of-the-art cancer treatment facility with government officials, members of the Boards of Overseers and Managers, and staff. Opening for patient care next month, the 750,000-square-foot

Learn how MSK works to keep people with cancer heart healthy.

… Thursday, February 13, 2020 Summary People with cancer are at a significantly higher risk of heart disease during and after treatment. The issue has taken on more importance because people are living longer after a cancer diagnosis. Cancer is challenging enough on its own. Now, a recent study published

New MSK research supported the approval of a new treatment for ER-positive, HER2-negative advanced breast cancer; suggests a new strategy for overcoming resistance to Akt inhibitors in patients with PTEN-mutated prostate cancers; provides new understanding of B cell lymphomas that could lead to new treatments; examines using ChatGPT to help capture patient-reported outcomes; and developed the first customizable, scalable model for palliative care training for emergency departments.

… Thursday, February 13, 2025 New research from Memorial Sloan Kettering Cancer Center (MSK) supported the approval of a new treatment for ER-positive, HER2-negative advanced breast cancer; suggests a new strategy for overcoming resistance to Akt inhibitors in patients with PTEN -mutated prostate cancers

After treatment for rectal cancer, Roxanne Joseph is back to enjoying an active life with her husband, Rory, and their two children. Recent research by MSK computational biologist Henry Walch is shedding light on why colorectal cancer has been more difficult to treat in many Black people.

… Saturday, July 1, 2023 By Jim Stallard At first, Roxanne Joseph thought she was just hitting the gym weights too hard. The Brooklyn police officer was in top physical condition at age 41 and felt great. But after noticing blood in her stool, she remembered her uncle’s colorectal cancer diagnosis four